Tildrakizumab improves high burdensome symptoms and overall well-being in patients with moderate-to-severe plaque psoriasis
| dc.contributor.author | Augustin, Matthias | |
| dc.contributor.author | Mrowietz, Ulrich | |
| dc.contributor.author | Dauden, Esteban | |
| dc.contributor.author | Weger, Wolfgang | |
| dc.contributor.author | Maul, Julia-Tatjana | |
| dc.contributor.author | Zurich, Graz | |
| dc.contributor.author | Laws, Phillip | |
| dc.contributor.author | Naldi, Luigi | |
| dc.contributor.author | Mburu, Sicily | |
| dc.contributor.author | de Jong, Elke | |
| dc.contributor.author | Kasujee, Ismail | |
| dc.contributor.author | Sommer, Rachel | |
| dc.date.accessioned | 2026-11-05T11:01:40Z | |
| dc.date.issued | 2025 | |
| dc.description.issue | 3 | |
| dc.description.pages | AB328-AB328 | |
| dc.description.sponsorship | These studies were funded by Almirall. | |
| dc.description.volume | 93 | |
| dc.identifier.issn | 0190-9622 | |
| dc.identifier.issn | 1097-6787 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/10777 | |
| dc.identifier.wos | WOS:001574372800108 | |
| dc.language.iso | en | |
| dc.publisher | MOSBY-ELSEVIER | |
| dc.relation.funding | Almirall(Almirall) | |
| dc.relation.funding | Almirall | |
| dc.relation.ispartof | JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | |
| dc.subject | Dermatology | |
| dc.title | Tildrakizumab improves high burdensome symptoms and overall well-being in patients with moderate-to-severe plaque psoriasis | |
| dc.type | Meeting Abstract | |
| oaire.citation.edition | Science Citation Index Expanded (SCI-EXPANDED) | |
| oaire.citation.endPage | AB328 | |
| oaire.citation.issue | 3 | |
| oaire.citation.startPage | AB328 | |
| oaire.citation.volume | 93 | |
| person.identifier.rid | L-4418-2015 |